Clinical end point acceptance limit [Study As­sess­ment]

posted by ElMaestro  – Denmark, 2019-04-05 08:51 (849 d 22:59 ago) – Posting: # 20126
Views: 2,424

Hello to you too, PKS,

» Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)

What does your protocol say on exactly that matter?

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,596 posts in 4,516 threads, 1,532 registered users;
online 15 (0 registered, 15 guests [including 4 identified bots]).
Forum time: Monday 07:50 CEST (Europe/Vienna)

Imagine if every Thursday your shoes exploded
if you tied them the usual way.
This happens to us all the time with computers,
and nobody thinks of complaining.    Jef Raskin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5